ADMA vs. UFPT
ADMA (ADMA Biologics, Inc.) and UFPT (UFP Technologies, Inc.) are both stocks. Both are in the Healthcare sector — ADMA in Biotechnology, UFPT in Medical Devices. Over the past 10 years, ADMA returned 1.08%/yr vs 26.04%/yr for UFPT. At a 0.13 correlation, their price movements are largely independent.
Performance
ADMA vs. UFPT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ADMA achieves a -55.81% return, which is significantly lower than UFPT's 2.11% return. Over the past 10 years, ADMA has underperformed UFPT with an annualized return of 1.08%, while UFPT has yielded a comparatively higher 26.04% annualized return.
ADMA
- 1D
- 1.13%
- 1M
- -1.35%
- YTD
- -55.81%
- 6M
- -58.43%
- 1Y
- -60.89%
- 3Y*
- 28.26%
- 5Y*
- 34.37%
- 10Y*
- 1.08%
UFPT
- 1D
- 1.27%
- 1M
- -1.67%
- YTD
- 2.11%
- 6M
- 5.06%
- 1Y
- -4.53%
- 3Y*
- 10.66%
- 5Y*
- 31.64%
- 10Y*
- 26.04%
ADMA vs. UFPT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ADMA ADMA Biologics, Inc. | -55.81% | 6.36% | 279.42% | 16.49% | 175.18% | -27.69% | -51.25% | 67.36% | -25.55% | -37.30% |
UFPT UFP Technologies, Inc. | 2.11% | -9.19% | 42.12% | 45.93% | 67.79% | 50.77% | -6.07% | 65.15% | 8.06% | 9.23% |
Correlation
The correlation between ADMA and UFPT is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.22 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.24 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.24 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.16 |
Correlation (All Time) Calculated using the full available price history since Oct 17, 2013 | 0.13 |
The correlation between ADMA and UFPT shifts across timeframes, from 0.13 (all time) to 0.24 (3 years), reflecting how their relationship changes across market environments.
Fundamentals
ADMA:
$1.93B
UFPT:
$1.77B
ADMA:
$0.68
UFPT:
$8.81
ADMA:
11.91
UFPT:
25.73
ADMA:
3.86
UFPT:
2.90
ADMA:
4.95
UFPT:
4.03
ADMA:
$509.86M
UFPT:
$608.85M
ADMA:
$312.42M
UFPT:
$172.62M
ADMA:
$218.74M
UFPT:
$111.39M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ADMA vs. UFPT — Risk / Return Rank
ADMA
UFPT
ADMA vs. UFPT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ADMA Biologics, Inc. (ADMA) and UFP Technologies, Inc. (UFPT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ADMA | UFPT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.01 | ||
| Sortino ratioReturn per unit of downside risk | -1.91 | ||
| Omega ratioGain probability vs. loss probability | 0.77 | 1.02 | -0.25 |
| Calmar ratioReturn relative to maximum drawdown | -0.94 | -0.15 | -0.79 |
| Martin ratioReturn relative to average drawdown | -1.81 | -0.27 | -1.54 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ADMA | UFPT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -1.12 | -0.10 | -1.01 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.58 | 0.72 | -0.14 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.02 | 0.66 | -0.64 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.01 | 0.16 | -0.17 |
Drawdowns
ADMA vs. UFPT - Drawdown Comparison
The maximum ADMA drawdown since its inception was -91.28%, roughly equal to the maximum UFPT drawdown of -88.53%. Use the drawdown chart below to compare losses from any high point for ADMA and UFPT.
Loading charts...
Drawdown Indicators
| ADMA | UFPT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -91.28% | -88.53% | -2.75% |
Max Drawdown (1Y)Largest decline over 1 year | -65.25% | -30.69% | -34.56% |
Max Drawdown (3Y)Largest decline over 3 years | -68.99% | -48.31% | -20.68% |
Max Drawdown (5Y)Largest decline over 5 years | -68.99% | -48.31% | -20.68% |
Max Drawdown (10Y)Largest decline over 10 years | -86.11% | -48.31% | -37.80% |
Current DrawdownCurrent decline from peak | -67.12% | -36.75% | -30.37% |
Average DrawdownAverage peak-to-trough decline | -53.05% | -32.24% | -20.81% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 33.62% | 16.77% | +16.85% |
Volatility
ADMA vs. UFPT - Volatility Comparison
ADMA Biologics, Inc. (ADMA) has a higher volatility of 11.89% compared to UFP Technologies, Inc. (UFPT) at 9.41%. This indicates that ADMA's price experiences larger fluctuations and is considered to be riskier than UFPT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ADMA | UFPT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.89% | 9.41% | +2.48% |
Volatility (6M)Calculated over the trailing 6-month period | 45.36% | 30.26% | +15.10% |
Volatility (1Y)Calculated over the trailing 1-year period | 54.73% | 43.47% | +11.26% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 59.46% | 44.22% | +15.24% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 69.05% | 39.62% | +29.43% |
Dividends
ADMA vs. UFPT - Dividend Comparison
Neither ADMA nor UFPT has paid dividends to shareholders.
Financials
ADMA vs. UFPT - Financials Comparison
This section allows you to compare key financial metrics between ADMA Biologics, Inc. and UFP Technologies, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ADMA vs. UFPT - Profitability Comparison
ADMA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported a gross profit of 80.75M and revenue of 114.49M. Therefore, the gross margin over that period was 70.5%.
UFPT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, UFP Technologies, Inc. reported a gross profit of 44.36M and revenue of 154.20M. Therefore, the gross margin over that period was 28.8%.
ADMA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported an operating income of 58.27M and revenue of 114.49M, resulting in an operating margin of 50.9%.
UFPT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, UFP Technologies, Inc. reported an operating income of 23.37M and revenue of 154.20M, resulting in an operating margin of 15.2%.
ADMA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported a net income of 45.33M and revenue of 114.49M, resulting in a net margin of 39.6%.
UFPT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, UFP Technologies, Inc. reported a net income of 17.50M and revenue of 154.20M, resulting in a net margin of 11.4%.
Frequently Asked Questions
ADMA and UFPT have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ADMA has higher volatility (11.89%) compared to UFPT (9.41%). In terms of maximum drawdown, ADMA dropped -91.28% vs UFPT's -88.53%.
UFPT currently has the higher Sharpe Ratio (-0.10 vs -1.12), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ADMA and UFPT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer